Litigation Details for Biogen International GmbH v. Sawai USA, Inc. (D. Del. 2017)
✉ Email this page to a colleague
Biogen International GmbH v. Sawai USA, Inc. (D. Del. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-06-30 |
Court | District Court, D. Delaware | Date Terminated | 2019-11-14 |
Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
Jury Demand | Defendant | Referred To | |
Patents | 7,803,840; 8,399,514; 8,759,393 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Biogen International GmbH v. Sawai USA, Inc.
Details for Biogen International GmbH v. Sawai USA, Inc. (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2017-06-30 | 4 | Patent/Trademark Report to Commissioner | ,320,999; 6,509,376; 7,619,001; 7,803,840; 8,759,393. (crb) (Entered: 07/03/2017) 30 June 2017 … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,399,514; 7,320,999… 14 November 2019 1:17-cv-00875 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |